Octreotide for advanced hepatocellular carcinoma: a meta-analysis of randomized controlled trials

被引：0
|
作者：
Tian-Kang Guo
Xiang-Yong Hao
Bin Ma
Ke-Hu Yang
Yi-Ping Li
Hong-Ling Li
Yuan-Hui Gu
Hui Cai
Ya-Li Liu
Yuan Li
Wei-Peng Zhan
机构：
[1] The People’s Hospital of Gansu Province,
[2] Evidence-Based Medicine Center of Lanzhou University,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2009年 / 135卷
关键词：
Hepatocellular carcinoma; Octreotide; Liver disease; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1685 / 1692
页数：7
相关论文
共 50 条
  • [31] Alternative treatment strategies to sorafenib in patients with advanced hepatocellular carcinoma: a meta-analysis of randomized Phase III trials
    Wang, Hui
    Wang, Hefang
    Yu, Zhichong
    Liu, Honghao
    ONCOTARGETS AND THERAPY, 2018, 11 : 5195 - 5201
  • [32] Survival Trends in Sorafenib for Advanced Hepatocellular Carcinoma: A Reconstructed Individual Patient Data Meta-analysis of Randomized Trials
    Tan, Darren Jun Hao
    Tang, Ansel Shao Pin
    Lim, Wen Hui
    Ng, Cheng Han
    Nah, Benjamin
    Fu, Clarissa
    Xiao, Jieling
    Koh, Benjamin
    Tay, Phoebe Wen Lin
    Tan, Eunice X.
    Teng, Margaret
    Syn, Nicholas
    Muthiah, Mark D.
    Tamaki, Nobuharu
    Lee, Sung Won
    Kim, Beom Kyung
    Yau, Thomas
    Vogel, Arndt
    Loomba, Rohit
    Huang, Daniel Q.
    LIVER CANCER, 2023, 12 (05) : 445 - 456
  • [33] Octreotide Therapy for Hepatocellular Carcinoma: A Systematic Review of the Evidence from Randomized Controlled Trials
    Jia, Wei-Dong
    Zhang, Chuan-Hai
    Xu, Ge-Liang
    Ge, Yong-Sheng
    Wang, Wei
    HEPATO-GASTROENTEROLOGY, 2010, 57 (98) : 292 - 299
  • [34] MICROWAVE ABLATION VERSUS RADIOFREQUENCY ABLATION FOR HEPATOCELLULAR CARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Fazli, Obaid O. F.
    Roberts, Stuart Skr
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 121 - 121
  • [35] Surrogacy of Time to Progression for Overall Survival in Advanced Hepatocellular Carcinoma Treated with Systemic Therapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Terashima, Takeshi
    Yamashita, Tatsuya
    Toyama, Tadashi
    Arai, Kuniaki
    Kawaguchi, Kazunori
    Kitamura, Kazuya
    Yamashita, Taro
    Sakai, Yoshio
    Mizukoshi, Eishiro
    Honda, Masao
    Kaneko, Shuichi
    LIVER CANCER, 2019, 8 (02) : 130 - 139
  • [36] Safety of Bevacizumab in Patients with Advanced Cancer: A Meta-Analysis of Randomized Controlled Trials
    Geiger-Gritsch, Sabine
    Stollenwerk, Bjoern
    Miksad, Rebecca
    Guba, Beate
    Wild, Claudia
    Siebert, Uwe
    ONCOLOGIST, 2010, 15 (11): : 1179 - 1191
  • [37] Hypertension: meta-analysis of randomized controlled trials
    Chen, Ken
    Kou, Xun
    Han, Yu
    Zhou, Lin
    Zeng, Chunyu
    CARDIOLOGY, 2013, 126 : 165 - 165
  • [38] Immune checkpoint inhibitors therapy in advanced bladder carcinoma: A meta-analysis of phase III randomized controlled trials
    Patel, Rushin
    Chitkara, Akshit
    Patel, Zalak
    Patel, Mrunal
    Anamika, Fnu
    Trivedi, Shivang
    Ramaswamy, Bhuvaneswari
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [39] VEGF pathway-targeted therapy for advanced renal cell carcinoma: A meta-analysis of randomized controlled trials
    Liu, Fei
    Chen, Xianguo
    Peng, Ejun
    Guan, Wei
    Li, Youyuan
    Hu, Zhiquan
    Ye, Zhangqun
    Zhuang, Qianyuan
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2011, 31 (06) : 799 - 806
  • [40] Efficacy of targeted therapy for advanced renal cell carcinoma: A systematic review and meta-analysis of randomized controlled trials
    Wei, Chao
    Wang, Shen
    Ye, Zhangqun
    Chen, Zhiqiang
    INTERNATIONAL BRAZ J UROL, 2018, 44 (02): : 219 - 237
12345